In: Finance
Forecast an Income Statement
Following is the income statement for Medtronic PLC for the year ended April 29, 2016.
| Consolidated Statements of Income | Apr. 29, 2016 | Apr. 24, 2015 | Apr. 25, 2014 | |||
|---|---|---|---|---|---|---|
| Net sales | $29,944 | $20,261 | $17,005 | |||
| Costs and expenses | ||||||
| Cost of products sold | 9,283 | 6,309 | 4,333 | |||
| Research and development expense | 2,224 | 1,640 | 1,477 | |||
| Selling, general, and administrative expense | 9,469 | 6,904 | 5,847 | |||
| Special charges (gains), net | 70 | (38) | 40 | |||
| Restructuring charges, net | 290 | 237 | 78 | |||
| Certain litigation charges, net | 26 | 42 | 770 | |||
| Acquisition-related items | 283 | 550 | 117 | |||
| Amortization of intangible assets | 1,931 | 733 | 349 | |||
| Other expense, net | 107 | 118 | 181 | |||
| Operating profit | 6,261 | 3,766 | 3,813 | |||
| Interest expense, net | 955 | 280 | 108 | |||
| Income from operations before income taxes | 5,306 | 3,486 | 3,705 | |||
| Provision for income taxes | 1,008 | 811 | 640 | |||
| Net income | $4,298 | $2,675 | $3,065 |
Use the following assumptions to prepare a forecast of the company's income statement for FY2017.
| Net sales increase | 20% | ||||
| Cost of products sold | 31.7% |
of net sales |
|||
| Research and development expense | 7.7% |
of net sales |
|||
| Selling, general, and administrative expense | 32.8% |
of net sales |
|||
| Special charges (gains), net | $0 | ||||
| Certain litigation charges, net | $0 | ||||
| Restructuring charges, net | 75% |
of 2016 expense |
|||
| Acquistion-related items | 1.0% | of net sales | |||
| Amortization of intangible assets | No change | ||||
| Other expense, net and Interest expense, net | No change | ||||
| Provision for income taxes | 20% |
of pre-tax income |
Instructions:
Round answers to the nearest whole number.
Use rounded answers for any subsequent computations.
Do not use negative signs with any of your answers.
| Medtronic Inc. | ||||
|---|---|---|---|---|
| Forecasted Consolidated Statement of Income | ||||
|
in Millions |
EST. 2017 | |||
| Net sales | $Answer | |||
| Costs and expenses | ||||
| Cost of products sold | Answer | |||
| Research and development expense | Answer | |||
| Selling, general, and administrative expense | Answer | |||
| Restructuring charges, net | Answer | |||
| Acquisition-related items | Answer | |||
| Amortization of intangible assets | Answer | |||
| Other expense, net | Answer | |||
| Operating profit | Answer | |||
| Interest expense, net | Answer | |||
| Income from operations before income taxes | Answer | |||
| Provision for income taxes | Answer | |||
| Net income | $Answer | |||
| Net sales increase | 20% | =29944*120% | 35,933 | ||||||
| Cost of products sold | 31.70% | of net sales | =35933*31.7% | 11,391 | |||||
| Research and development expense | 7.70% | of net sales | =35933*7.7% | 2,767 | |||||
| Selling, general, and administrative expense | 32.80% | of net sales | =35933*32.8% | 11,786 | |||||
| Special charges (gains), net | $0 | - | |||||||
| Certain litigation charges, net | $0 | - | |||||||
| Restructuring charges, net | 75% | of 2016 expense | =290*75% | 218 | |||||
| Acquistion-related items | 1.00% | of net sales | =35933*1% | 359 | |||||
| Amortization of intangible assets | No change | 1,931 | 1,931 | ||||||
| Other expense, net and Interest expense, net | No change | =107+955 | 1,062 | ||||||
| Total cost | 29,513 | ||||||||
| Net income = Revenue - cost | 6,419 | ||||||||
| Tax @ 20% | =6419*20% | 1,283.90 | |||||||
| Answer | |||||||||
| Net sales | 35,933 | ||||||||
| Costs and expenses | |||||||||
| Cost of products sold | 11,391 | ||||||||
| Research and development expense | 2,767 | ||||||||
| Selling, general, and administrative expense | 11,786 | ||||||||
| Restructuring charges, net | 218 | ||||||||
| Acquisition-related items | 359 | ||||||||
| Amortization of intangible assets | 1,931 | ||||||||
| Other expense, net and Interest expense, net | 1,062 | ||||||||
| Provision for income taxes | 1,284 |